CorMedix, Inc. (CRMD)
7.39
+0.26
(+3.65%)
USD |
NASDAQ |
Apr 17, 16:00
7.395
0.00 (0.00%)
After-Hours: 20:00
CorMedix SG&A Expense (Quarterly) : 39.58M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Pfizer Inc. | 4.162B |
| Altimmune, Inc. | 10.51M |
| Theravance Biopharma, Inc. | 20.96M |
| REGENXBIO, Inc. | 22.38M |
| Mirum Pharmaceuticals, Inc. | 74.13M |